News
More news
Featured Story
Baral Granted $1.87 Million by NIH to explore cell interactions that fight inflammatory disease
Pankaj Baral, Kansas State University assistant professor and CBID Pilot Project leader, has been awarded a Maximizing Investigators' Research Award, or MIRA, by the National Institute of General Medical Sciences. This early stage investigator grant will fund his study of how immune cells and sensory neurons affect tissue inflammation — work that could lead to improved methods of treating inflammatory diseases.
More news
Baral Granted $1.87 Million by NIH to explore cell interactions that fight inflammatory disease
Pankaj Baral, Kansas State University assistant professor and CBID Pilot Project leader, has been awarded a Maximizing Investigators' Research Award, or MIRA, by the National Institute of General Medical Sciences. This early stage investigator grant will fund his study of how immune cells a
5 CBID participants earn promotion and tenure
Congratulations to five CBID faculty who have earned promotion and tenure this spring.
Orozco Nominated For 2024 Undergraduate Research Mentor Award
Robin Orozco, CBID Research Project Leader, has been nominated for a 2024 Undergraduate Research Mentor Award along with CBID faculty mentors Kristi Neufeld and Michael Hageman.
Ferreira Awarded New Faculty Research Development Award
Rosana Ferreira, CBID Research Project leader, has been awarded a New Faculty Research Development Award for her project titled "Bacterial Interactions and Their Role in the Skin Microbiome Composition." This one year
Teruna Siahaan Awarded An NIH R01
Teruna Siahaan, Aya and Takeru Higuchi Distinguished Professor of Pharmaceutical Chemistry, has been awarded an NIH R01 grant for
Study reports new compound halting replication of COVID by targeting ‘Mac-1’ protein in cell models
Research appearing in the Journal of Medicinal Chemistry shows for the first time SARS-CoV-2, the virus responsible for COVID-19, can be inhibited from replicating in living cell cultures using a compound that targets “Mac-1,” a protein key to defending SARS-CoV-2 against the human immune re
Orozco, CBID Research Project Leader, Finds Gene that Enhances Anti-Viral Immunity
Robin Orozco, an assistant professor of Molecular Biosciences at the University of Kansas, has unveiled new research that explores how a common mutation in the human population changes immune response during a virus infection. Dr.
Siahaan and Fehr recognized as 2023 KU innovators
KU and its medical center are filled with great innovators striving to find creative solutions for the problems facing our world. Today, the KU Center for Technology Commercialization wants to thank all members of KU's research community for their creativity and ingenuity.
Lynn Hancock Awarded Newest CBID Pilot Project
Lynn Hancock, Associate Professor, Department of Molecular Biosciences, University of Kansas, is the new recipient of a CBID pilot project award. Dr. Hancock's project title is “Glycobiology at the interface of the host-microbe interaction."